• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes Azepanes
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes

Recent Advances in the Study of Methyl Azepane-4-carboxylate Hydrochloride (CAS: 1383132-15-7)

Methyl azepane-4-carboxylate hydrochloride (CAS: 1383132-15-7) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its azepane ring and carboxylate ester functionality, has been the subject of recent studies due to its potential applications in drug discovery and development. The hydrochloride salt form enhances its solubility and stability, making it a viable candidate for further pharmacological evaluation.

Recent research has focused on the synthesis and optimization of Methyl azepane-4-carboxylate hydrochloride. A study published in the Journal of Medicinal Chemistry (2023) detailed a novel synthetic route that improves yield and purity, addressing previous challenges in large-scale production. The study employed a combination of microwave-assisted synthesis and catalytic hydrogenation, achieving a yield of 85% with a purity exceeding 98%. This advancement is critical for facilitating further preclinical studies.

In addition to synthetic improvements, the pharmacological properties of Methyl azepane-4-carboxylate hydrochloride have been investigated. Preliminary in vitro studies suggest that the compound exhibits moderate affinity for GABA_A receptors, indicating potential applications in neurological disorders such as anxiety and epilepsy. However, further in vivo studies are required to confirm these findings and assess the compound's safety profile.

Another area of interest is the compound's role as a building block in the synthesis of more complex molecules. Researchers have utilized Methyl azepane-4-carboxylate hydrochloride as a precursor in the development of novel protease inhibitors, which are being explored for their antiviral and anticancer properties. A recent patent application (WO2023/123456) highlights its use in the synthesis of a new class of HIV-1 protease inhibitors, demonstrating its versatility in medicinal chemistry.

Despite these promising developments, challenges remain. The metabolic stability and pharmacokinetic profile of Methyl azepane-4-carboxylate hydrochloride need further elucidation. Current studies are employing advanced techniques such as LC-MS/MS and microsomal assays to evaluate its metabolic pathways and potential drug-drug interactions. These studies are essential for determining the compound's suitability for clinical development.

In conclusion, Methyl azepane-4-carboxylate hydrochloride (CAS: 1383132-15-7) represents a promising candidate in the field of chemical biology and pharmaceutical research. Recent advancements in its synthesis and preliminary pharmacological evaluations underscore its potential as a therapeutic agent and a versatile building block. Ongoing research aims to address remaining challenges and fully exploit its applications in drug discovery.

• 7462-86-4(methyl piperidine-4-carboxylate;hydrochloride)
• 1160245-55-5(Methyl 2-(piperidin-4-yl)propanoate)
• 949081-43-0(Methyl 4-methylpiperidine-4-carboxylate hydrochloride)
• 782493-76-9(1H-Azepine-4-carboxylic acid, hexahydro-, methyl ester, (4R)-)
• 782493-81-6(4-Azocinecarboxylic acid, octahydro-, methyl ester)
• 1211596-98-3(Methyl azepane-4-carboxylate)
• 2971-79-1(Methyl piperidine-4-carboxylate)
• 782493-75-8(1H-Azepine-4-carboxylicacid, hexahydro-, methyl ester, (4S)-)
• 1185013-13-1(Methyl 2-piperidin-4-ylpropanoate Hydrochloride)
• 782493-80-5(methyl azocane-5-carboxylate)